Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Conserved Binding Sites01:49

Conserved Binding Sites

4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
Ligand Binding Sites02:40

Ligand Binding Sites

12.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.9K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.2K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

12.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.9K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

2.8K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oxidative trifunctionalization of indoles with 2-aminobenzyl alcohols: access to iodo-indoloquinoline scaffolds.

Organic & biomolecular chemistry·2026
Same author

A Novel Approach for the Fabrication of Polarization-Selectivity UV Photosynapse Devices With PdSe<sub>2</sub>/ a-plane GaN Heterostructures.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

MambaCell: A Self-Supervised Mamba Framework for Multi-Task Cell Representation Learning.

IEEE journal of biomedical and health informatics·2026
Same author

Correction to Rapid Substrate Neutralization via Side-Chain Hydroxylated Copolymers for Efficient Vertical Alignment of Block Copolymers.

ACS macro letters·2026
Same author

TransGAT-DTI: Transformer and Graph Attention Network for Drug-Target Interaction Prediction.

Journal of computational biology : a journal of computational molecular cell biology·2026
Same author

Multi-domain based heterogeneous network for drug-target interaction prediction.

Artificial intelligence in medicine·2026

Related Experiment Video

Updated: Jul 6, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.6K

TransVAE-DTA: Transformer and variational autoencoder network for drug-target binding affinity prediction.

Changjian Zhou1, Zhongzheng Li2, Jia Song3

  • 1School of life sciences, Northeast Agricultural University, Harbin, PR China; Department of Data and Computing, Northeast Agricultural University, Harbin, PR China.

Computer Methods and Programs in Biomedicine
|January 5, 2024
PubMed
Summary

This study introduces TransVAE-DTA, a novel framework for drug-target binding affinity prediction. It enhances drug discovery by effectively modeling protein long-distance relationships and drug-target interactions.

Keywords:
Drug discoveryDrug-target binding affinity predictionTransformerVariational autoencoder

More Related Videos

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

1.9K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.0K

Related Experiment Videos

Last Updated: Jul 6, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.6K
Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

1.9K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.0K

Area of Science:

  • Computational drug discovery
  • Bioinformatics
  • Machine learning in pharmacology

Background:

  • Computational drug-target binding affinity (DTA) prediction is crucial for drug discovery and repurposing.
  • Existing methods struggle with protein long-distance relationships and simple interaction modeling.

Purpose of the Study:

  • To address limitations in current DTA prediction methods.
  • To propose a novel framework, TransVAE-DTA, for improved DTA prediction.

Main Methods:

  • Combines Transformer architecture for target representation and Variational Autoencoder (VAE) for drug structure encoding.
  • Introduces an adaptive attention pooling (AAP) module for feature fusion.
  • Maximizes the lower bound of the joint likelihood of drug, target, and their DTAs.

Main Results:

  • TransVAE-DTA demonstrates superior performance in DTA prediction.
  • Validation conducted on the public Davis and KIBA datasets.

Conclusions:

  • TransVAE-DTA offers a new approach for engineering drug-target interactions.
  • The framework advances the field of computational drug discovery.